| Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619) |
|---|
| 01/17/2002 | WO2002004429A1 Pyrimidine derivatives |
| 01/17/2002 | WO2002004428A2 Synthesis of chlorinated pyrimidines |
| 01/17/2002 | WO2002004407A2 7-substituted tetracycline compounds |
| 01/17/2002 | WO2002004402A1 Ester derivatives |
| 01/17/2002 | WO2001059067A3 A group of anti-cancer compounds with specific structure and their production method |
| 01/17/2002 | WO2001042211A3 Detection of transmembrane potentials by optical methods |
| 01/17/2002 | US20020007070 For inhibiting loss of blood platelets; inhibiting formation of blood platelet aggregates, fibrin, thrombus, and embolus; anticoagulants embedded in devices for blood collection, circulation, storage (catheters, dialysis machines); stents |
| 01/17/2002 | US20020007063 Electronegatively substituted pyrimidines and intermediates leading to RNFX |
| 01/17/2002 | US20020007062 Enyme inhibitors for treating neurodegenerative diseases; inhibition of lipidic peroxidation and nitrogen oxide synthase in warm-blooded animal; for treatment of cardiovascular/brain disorders |
| 01/17/2002 | US20020006958 Substituted aminosalicylic acid amides with fungicidal effect and intermediate products for production thereof |
| 01/17/2002 | US20020006929 Antiarrhythmia agent, antiproliferative agent |
| 01/17/2002 | US20020006922 Metalloprotease inhibitors |
| 01/17/2002 | DE10033337A1 Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel Biphenylcarbonsäureamide, their preparation and their use as medicaments |
| 01/17/2002 | CA2415468A1 Ester derivatives |
| 01/16/2002 | EP1171443A1 Bicyclic heteroaromatic compounds useful as lh agonists |
| 01/16/2002 | EP1171442A1 Xanthine derivatives and analogs as cell signalling inhibitors |
| 01/16/2002 | EP1171435A2 Pyrimidine-2-one derivatives as integrin receptor ligands |
| 01/16/2002 | EP1171427A1 Process for the preparation of 6-(perfluoroalkyl) uracil compounds from urea compounds |
| 01/16/2002 | EP1171426A1 Cross-linking agent based on pyrimidine used for thermohardenable compositions |
| 01/16/2002 | EP0832073B1 Quinazolines and pharmaceutical compositions |
| 01/16/2002 | CN1077886C Amidino derivatives useful as nitric oxide synthase inhibitors |
| 01/15/2002 | US6339155 Process for producing 3-phenyluracil compounds |
| 01/15/2002 | US6339090 For therapy of benign prostatic hyperplasia |
| 01/15/2002 | US6339089 Antihypoxic agents; chronic obstructive pulmonary disease; vasoconstriction; reduces blood partial pressure of carbon dioxide; respiratory disorders; under oxygen inhalation treatment |
| 01/15/2002 | US6339088 Composition for treatment of external secretion disorders except hypol acrimation |
| 01/15/2002 | US6339082 Tricyclic compounds, preparation method and said method intermediates, application as medicines and pharmaceutical compositions containing same |
| 01/15/2002 | US6339044 N-P-Cyanoaryl nitrogen-containing heterocycles having pendent sulfur-containing groups |
| 01/15/2002 | CA2199995C Use of 2,4-diamino pyrimidine 3-oxide or a salt thereof for treating collagen maturation and structuring disorders |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002714A2 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002539A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | WO2002002534A1 Quinazolines with therapeutic use |
| 01/10/2002 | WO2002002512A2 Compounds to treat alzheimer's disease |
| 01/10/2002 | WO2001070709A3 3-oxy-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadazine-1,1-dioxide derivatives having diuretic and/or natriuretic activity |
| 01/10/2002 | US20020004600 Process for the preparation of substituted pyrimidines |
| 01/10/2002 | US20020004599 Hardening of polymers |
| 01/10/2002 | US20020004503 Viricides |
| 01/10/2002 | US20020004501 Therapy for muscular disorders, urogenital disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | US20020004494 Muscular disorders, gastrointestinal disorders, respiratory system disorders |
| 01/10/2002 | DE10031971A1 Polymorphe Formen/Hydrate von N-[4-(3-Chlor-4-fluor-phenylamino)-7-(3-morpholin-4-yl-propoxy)-chinazolin-6-yl]-acrylamid Dihydrochlorid, Verfahren zu ihrer Herstellung sowie die Verwendung derselben zur Herstellung von Medikamenten mit irreversibler Tyrosinkinasehemmwirkung Polymorphic forms / hydrates of N- [4- (3-chloro-4-fluoro-phenylamino) -7- (3-morpholin-4-yl-propoxy) -quinazolin-6-yl] -acrylamide dihydrochloride, processes for their preparation and to the use thereof for the preparation of medicaments with irreversible Tyrosinkinasehemmwirkung |
| 01/10/2002 | CA2414461A1 Aryl phenylheterocyclyl sulfide derivatives and their use as cell adhesion-inhibiting anti-inflammatory and immune-suppressive agents |
| 01/10/2002 | CA2411624A1 Electroluminescent iridium compounds with fluorinated phenylpyridines, phenylpyrimidines, and phenylquinolines and devices made with such compounds |
| 01/10/2002 | CA2410651A1 Compounds to treat alzheimer's disease |
| 01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
| 01/09/2002 | EP1169312A2 Glucokinase activators |
| 01/09/2002 | EP1169310A1 Process for preparing mkc-442 |
| 01/09/2002 | EP1169308A1 Processes and intermediates for the preparation of 1,3-oxazin-6-ones and uracils |
| 01/09/2002 | EP1169307A1 Pyrimidine compounds with pharmaceutical activity |
| 01/09/2002 | EP1169306A1 Dibenzoazulene derivatives for treating thrombosis, osteoporosis, arteriosclerosis |
| 01/09/2002 | EP1169293A1 Liquid crystal compounds |
| 01/09/2002 | EP1169038A1 Cyclic protein tyrosine kinase inhibitors |
| 01/09/2002 | EP1169031A1 Antimicrobial agents |
| 01/09/2002 | EP0996617B1 2,4-Dithi(oxo)-pyridin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists |
| 01/09/2002 | EP0858447B1 Methods of producing aminophenylsulphonyl carbamides and intermediate products for use in the process |
| 01/09/2002 | EP0607439B1 Nitrogenous heterocyclic compound |
| 01/09/2002 | CN1330649A Herbicidal-3-[benzo(ox/thi)azol-7-yl)-1H-pyrimidine-2,4-diones |
| 01/09/2002 | CN1330642A N-[4-(3-chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide, irreversible inihibotr of tyrosine kinases |
| 01/09/2002 | CN1330640A Cyclic hydrazine derivatives as TNF-alpha inhibitors |
| 01/09/2002 | CN1330593A Heat sensitive recording material |
| 01/09/2002 | CN1330069A Substituted 2-benzo [c] furanone compound, its preparing process and medicinal composition containing it |
| 01/08/2002 | US6337350 Inhibitors of formation of advanced glycation endproducts (AGEs) |
| 01/08/2002 | US6337340 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
| 01/08/2002 | US6337335 Enzyme inhibitors for autoimmune diseases, transplant rejection, grant versus host disease, hyperproliferative disorders and diseases in which cells receive pro-inflammatory signals. |
| 01/08/2002 | US6337334 Pyrimidine derivatives |
| 01/08/2002 | US6337332 Neuropeptide Y receptor antagonists |
| 01/08/2002 | US6337306 Herbicides for agriculture |
| 01/08/2002 | US6337034 Vinylene compounds and liquid-crystal composition |
| 01/03/2002 | WO2002000683A2 Novel chain-breaking antioxidants |
| 01/03/2002 | WO2002000644A1 Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases |
| 01/03/2002 | WO2002000638A2 Substituted phthalides as anti-convulsive drugs |
| 01/03/2002 | WO2002000630A1 Polymorphic forms/hydrates of n-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride |
| 01/03/2002 | WO2002000629A1 Iminopyrimidine nmda nr2b receptor antagonists |
| 01/03/2002 | WO2002000628A2 Synthesis of chlorinated pyrimidines |
| 01/03/2002 | WO2002000622A2 Aminoalcohol derivatives |
| 01/03/2002 | WO2002000607A1 Amide compounds and use thereof |
| 01/03/2002 | WO2001062233A3 Adenosine receptor modulators |
| 01/03/2002 | US20020002199 Suitable for treating type I diabetes, type II diabetes, impaired glucose tolerance, insulin resistance or obesity |
| 01/03/2002 | US20020002169 Protein kinase inhibitors |
| 01/03/2002 | US20020002162 Synergistic methods and compositions for treating cancer |
| 01/03/2002 | US20020002158 Potentiation of glutamate receptor function; treating central nervous system disorders |
| 01/03/2002 | US20020002152 Methionine aminopeptidase type 2 inhibitors; n'-((2S,3R)-3-amino-2-hydroxy-5-(isopropylsulfanyl)pentanoyl)-3-chloro benzoyl hydrazide |
| 01/03/2002 | DE10029169A1 Herbizide Mittel Herbicidal compositions |
| 01/03/2002 | CA2413752A1 Substituted phthalides as anti-convulsive drugs |
| 01/03/2002 | CA2412640A1 Iminopyrimidine nmda nr2b receptor antagonists |
| 01/03/2002 | CA2412535A1 Polymorphic forms/hydrates of n-[4-(3-chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)-quinazolin-6-yl]-acrylamide dihydrochloride |
| 01/02/2002 | EP1167356A2 Wet adhesion monomer and derived copolymers for latex paints |
| 01/02/2002 | EP1167342A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 01/02/2002 | EP1165576A1 Process for preparing amine platinum complexes |
| 01/02/2002 | EP1165560A1 2-hydroxy methylcyclopro pylidenemethyl purines and -pyrimidines as antiviral agents |
| 01/02/2002 | EP1165554A1 New endothelin converting enzyme inhibitors, their production and their use |
| 01/02/2002 | EP1165547A1 Substituted benzoylpyrazoles as herbicides |
| 01/02/2002 | EP1165530A2 Dihetero-substituted metalloprotease inhibitors |
| 01/02/2002 | EP1165524A2 Method of producing thiobarbituric acid derivatives |
| 01/02/2002 | EP1165523A1 Neurotrophic substituted pyrimidines |
| 01/02/2002 | EP1165522A1 Neurotrophic thio substituted pyrimidines |
| 01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
| 01/02/2002 | EP1165064A2 Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 01/02/2002 | EP1164848A1 Compositions and methods for preventing and treating sexual dysfunctions |
| 01/02/2002 | EP0996627A4 Method for solution phase synthesis of oligonucleotides and peptides |